Frequently Asked Questions

Shares issued and outstanding
As of November 30, 2017 there were 54,752,024 shares outstanding
Who can I contact for more information about the company?
Please contact Investor Relations
Tel: 352.327.3152
Email: investors@algernonpharmaceuticals.com
Who is Algernon Pharmaceutical's Transfer Agent?
CST Trust Company
1600 – 1066 W. Hastings St.
Vancouver, BC V6E 3X1 Tel: 604-235-3708
Who is Algernon Pharmaceutical's legal counsel?
McMillian LLP
Royal Centre, 1055 W. Georgia St, Suite 1500
PO Box 11117 Vancouver BC, V6E 4N7
Who is Algernon Pharmaceutical's independent auditor?
James Stafford Chartered Accountants
350 – 1111 Melville Street
Vancouver, BC V6E 3V6
Where is Algernon Pharmaceutical's stock traded and what is the symbol?
Canadian Securities Exchange CSE: AGN

Over-The-Counter (USA): OTCQB: AGNPF

Frankfurt Stock Exchange (DE): XFRA: AGW
How do I buy shares of the Company?
To buy shares of Algernon Pharmaceuticals you must contact a registered stockbroker; you cannot buy shares directly from us.
What is the Company’s fiscal year-end?
Algernon Pharmaceutical's fiscal year ends August 31.
Share via
Copy link
Powered by Social Snap